{"id":5778,"date":"2024-09-16T09:45:59","date_gmt":"2024-09-16T14:45:59","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5778"},"modified":"2025-06-27T11:11:21","modified_gmt":"2025-06-27T16:11:21","slug":"nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308b\u30e6\u30fc\u30ec\u30c6\u30a3\u30ca\u30fb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30fb\u30b9\u30dd\u30c3\u30c8\u30e9\u30a4\u30c8\u3068\u773c\u79d1\u672a\u6765\u30d5\u30a9\u30fc\u30e9\u30e0\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5778\" class=\"elementor elementor-5778\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-50949d8c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"50949d8c\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4a8f31fb\" data-id=\"4a8f31fb\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a361ec7 elementor-widget elementor-widget-text-editor\" data-id=\"a361ec7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u30c0\u30e9\u30b9\u30012024\u5e749\u670816\u65e5 \u2014 \u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308bNanoscope Therapeutics Inc.\u306f\u672c\u65e5\u30019\u670818\u65e5\u306b\u30b9\u30da\u30a4\u30f3\u306e\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEuretina Innovation Spotlight\u304a\u3088\u3073Ophthalmology Futures Forum\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p><p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u8996\u529b\u56de\u5fa9\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\uff1a\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u5149\u907a\u4f1d\u5b66<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u975e\u8840\u7ba1\u6027AMD\u304a\u3088\u3073IRD<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2024\u5e749\u670818\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u5f8c14\u664235\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<\/span><br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a\u00a0<\/b><a href=\"https:\/\/ccib.es\/en\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d0\u30eb\u30bb\u30ed\u30ca\u56fd\u969b\u4f1a\u8b70\u30bb\u30f3\u30bf\u30fc<\/a><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b>\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30fc\u30cd\u533b\u5b66\u535a\u58eb\u3001\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005<\/p><p>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u306b\u7d9a\u304f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u3001\u30d0\u30ed\u30fc\u30cd\u535a\u58eb\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u9ec4\u6591\u5909\u6027\u75c7\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u7642\u6cd5\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p><p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u6c11\u4e3b\u5316<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u4f01\u696d\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 3<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a0<span class=\"xn-chron\">2024\u5e749\u670818\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a0\u5348\u5f8c17\u664255\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a<\/b>\u00a0<a href=\"https:\/\/www.esferic.es\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30a8\u30b9\u30d5\u30a7\u30ea\u30c3\u30af \u30d0\u30eb\u30bb\u30ed\u30ca<\/a><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p><p>\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u4e2d\u3067\u3001\u907a\u4f1d\u6027\u7db2\u819c\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u304a\u3088\u3073\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\u306e\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u5149\u907a\u4f1d\u5b66\u7684\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u3064\u3044\u3066\u5f37\u8abf\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u30e2\u30cf\u30f3\u30c6\u30a3\u6559\u6388\u304c\u8b70\u9577\u3092\u52d9\u3081\u308b\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u306b\u3082\u53c2\u52a0\u3057\u307e\u3059\u3002\u00a0<span class=\"xn-person\">\u30c9\u30df\u30cb\u30af\u30fb\u30d5\u30a3\u30c3\u30b7\u30e3\u30fc<\/span>\u6559\u6388\u00a0<span class=\"xn-org\">\u30aa\u30c3\u30af\u30b9\u30d5\u30a9\u30fc\u30c9\u5927\u5b66<\/span>.<\/p><p><b>\u30d1\u30cd\u30eb\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u773c\u5e95\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u306e\u5c55\u671b\uff1a\u3053\u308c\u306f\u672c\u5f53\u306b\u30d3\u30b8\u30cd\u30b9\u306b\u306a\u308b\u306e\u304b\uff1f<br class=\"dnr\" \/><b>\u30d1\u30cd\u30eb\u65e5\u4ed8:<\/b>\u00a0<span class=\"xn-chron\">2024\u5e749\u670818\u65e5<\/span><br class=\"dnr\" \/><b>\u30d1\u30cd\u30eb\u30bf\u30a4\u30e0:<\/b>\u00a018:40 \u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c19\u664210\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<\/span><br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a<\/b>\u00a0<a href=\"https:\/\/www.esferic.es\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30a8\u30b9\u30d5\u30a7\u30ea\u30c3\u30af \u30d0\u30eb\u30bb\u30ed\u30ca<\/a><br class=\"dnr\" \/><b>\u30d1\u30cd\u30ea\u30b9\u30c8\uff1a<\/b>\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p><p>\u3053\u308c\u3089 2 \u3064\u306e\u30a4\u30d9\u30f3\u30c8\u306b\u306f\u3001\u696d\u754c\u306e\u30ea\u30fc\u30c0\u30fc\u3001\u81e8\u5e8a\u533b\u3001\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3001\u898f\u5236\u5f53\u5c40\u3001\u6295\u8cc7\u5bb6\u3068\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30ad\u30f3\u30b0\u306e\u6a5f\u4f1a\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u7d4c\u55b6\u9663\u306f\u3053\u308c\u3089\u306e\u30a4\u30d9\u30f3\u30c8\u306b\u51fa\u5e2d\u3057\u3001\u4f1a\u8b70\u306b\u3082\u51fa\u5e2d\u3067\u304d\u307e\u3059\u3002<\/p><p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3002 MCO-010 \u306f\u3001RP \u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u3067 FDA \u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073 FDA \u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p><p><b>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b><br class=\"dnr\" \/>\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br class=\"dnr\" \/>(212) 600-1902<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p><p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS Sept. 16, 2024\u00a0 \u2014 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, and geographic atrophy today announced presentations at the\u00a0Euretina Innovation Spotlight\u00a0and at\u00a0Ophthalmology Futures Forum\u00a0taking place on 18th September in\u00a0Barcelona, Spain. Details for the presentations are as follows: Title:\u00a0Breakthrough in Vision Restoration: Mutation-agnostic Optogenetics for Inherited Retinal Diseases and Geographic AtrophiesSession Title:\u00a0Nonneovascular AMD and IRDsSession Date:\u00a0September 18, 2024Session Time:\u00a014:35 p.m. CESTLocation:\u00a0Barcelona International Convention CenterPresenter:\u00a0Samuel Barone, MD, Chief Medical Officer In his presentation followed by a panel discussion, Dr. Barone will highlight the Multi-Characteristic Opsin (MCO) therapy pipelines of Nanoscope for the treatment of severe vision loss due to retinitis pigmentosa, Stargardt macular degeneration, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-16T14:45:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:11:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona\",\"datePublished\":\"2024-09-16T14:45:59+00:00\",\"dateModified\":\"2025-06-27T16:11:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/\"},\"wordCount\":392,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_EIS_LI_2024._V1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/\",\"name\":\"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_EIS_LI_2024._V1.jpg\",\"datePublished\":\"2024-09-16T14:45:59+00:00\",\"dateModified\":\"2025-06-27T16:11:21+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_EIS_LI_2024._V1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_EIS_LI_2024._V1.jpg\",\"width\":2000,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/16\\\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEuretina Innovation Spotlight\u304a\u3088\u3073Ophthalmology Futures Forum\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-09-16T14:45:59+00:00","article_modified_time":"2025-06-27T16:11:21+00:00","og_image":[{"width":2000,"height":2000,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona","datePublished":"2024-09-16T14:45:59+00:00","dateModified":"2025-06-27T16:11:21+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/"},"wordCount":392,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/","url":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEuretina Innovation Spotlight\u304a\u3088\u3073Ophthalmology Futures Forum\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg","datePublished":"2024-09-16T14:45:59+00:00","dateModified":"2025-06-27T16:11:21+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_EIS_LI_2024._V1.jpg","width":2000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/16\/nanoscope-therapeutics-announces-presentations-at-euretina-innovation-spotlight-and-ophthalmology-futures-forum-in-barcelona\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Presentations at Euretina Innovation Spotlight and Ophthalmology Futures Forum in Barcelona"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5778"}],"version-history":[{"count":8,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5778\/revisions"}],"predecessor-version":[{"id":9036,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5778\/revisions\/9036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5782"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}